Abstract
Valproate, carbamazapine, and other mood stabilizers have been found to increase the risk of thrombocytopenia, leucopenia, and/or anemia. However most previous studies have been small, were cross-sectional, included mostly adults, and did not use non-psychiatric controls. Our aims were to ascertain 1) whether geriatric psychiatry patients are at increased risk for these hematological conditions and 2) whether exposure to mood stabilizers and other clinical factors increase hematological adverse events in geriatric psychiatry patients.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
